BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
1.990
-0.030 (-1.49%)
At close: Oct 30, 2026, 4:00 PM EDT
1.950
-0.040 (-2.01%)
After-hours: Oct 30, 2026, 4:10 PM EDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $9.5 million as of October 30, 2026. Its market cap has decreased by 40.88% in one year.
Market Cap
9.50M
Enterprise Value
7.33M
1-Year Change
-40.88%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since July 25, 2011, BioLineRx's market cap has decreased from $68.58M to $9.50M, a decrease of -86.14%. That is a compound annual growth rate of -12.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 9.50M | -27.48% |
| Dec 31, 2025 | 13.10M | -44.21% |
| Dec 31, 2024 | 23.49M | -79.62% |
| Dec 31, 2023 | 115.26M | 305.33% |
| Dec 29, 2022 | 28.44M | -71.41% |
| Dec 30, 2021 | 99.46M | 66.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tvardi Therapeutics | 10.58M |
| Purple Biotech | 10.49M |
| Phio Pharmaceuticals | 9.99M |
| CalciMedica | 9.97M |
| Kiora Pharmaceuticals | 9.93M |
| GT Biopharma | 9.60M |
| Palatin Technologies | 9.58M |
| Lisata Therapeutics | 9.19M |